Recursion Pharmaceuticals (RXRX) EBITDA Margin (2020 - 2026)
Recursion Pharmaceuticals (RXRX) reported EBITDA Margin of -1522.83% for Q2 2026, down 730.14 percentage points from -792.69% a year earlier but up 158.75 percentage points from the prior quarter.
Recursion Pharmaceuticals (RXRX) EBITDA Margin (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Recursion Pharmaceuticals' EBITDA Margin came in at -848.87%, up 58.91 percentage points year-over-year; for FY2025, it came in at -755.79%, down 3.72 percentage points from FY2024.
- EBITDA Margin has declined for three consecutive years, though with a five-year change of +1280.35 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -752.07% in FY2024 (-21.48 pp), -730.58% in FY2023 (-143.35 pp), -587.23% in FY2022 (+1125.97 pp) and -1713.20% in FY2021 (+322.94 pp).
- Five-year quarterly EBITDA Margin spans a low of -3757.52% in Q4 2024 and a high of -250.03% in Q4 2025.
- Year over year, EBITDA Margin gained in two of the last eight quarters, with an average year-over-year change of -422.88 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q4 2025 (a gain of 3507.49 percentage points); the low point was Q4 2024 (a drop of 2918.51 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -1681.58% (Q1 2026), -250.03% (Q4 2025) and -2920.95% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Recursion Pharmaceuticals | 1.98 Bn | -627.04 Mn | -3.82 Mn | -1,522.83% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,522.83% |
| Mar 31, 2026 | -1,681.58% |
| Dec 31, 2025 | -250.03% |
| Sep 30, 2025 | -2,920.95% |
| Jun 30, 2025 | -792.69% |
| Mar 31, 2025 | -1,166.75% |
| Dec 31, 2024 | -3,757.52% |
| Sep 30, 2024 | -349.50% |
| Jun 30, 2024 | -635.19% |
| Mar 31, 2024 | -644.94% |
| Dec 31, 2023 | -839.01% |
| Sep 30, 2023 | -873.18% |
| Jun 30, 2023 | -691.40% |
| Mar 31, 2023 | -545.06% |
| Dec 31, 2022 | -422.40% |
| Sep 30, 2022 | -452.77% |
| Jun 30, 2022 | -826.23% |
| Mar 31, 2022 | -997.82% |
| Dec 31, 2021 | -2,476.27% |
| Sep 30, 2021 | -1,735.04% |
Recursion Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();